NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · page 13 of 30
NASH (Non-Alcoholic Steatohepatitis); NAFLD (Non-Alcoholic Fatty Liver Disease); T2DM (Type 2 Diabetes Mellitus); FPFV (First Patient First Visit); LPLV (Last Patient Last Visit).
Regulatory filing · other · establish_context · balanced density
Slide locked Sign in to view
Slide schematic 4/4
source-note 1/1 table 1/1 title 2/2
Components 4
source-note data action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.